<DOC>
	<DOCNO>NCT01636180</DOCNO>
	<brief_summary>REL-0609 trial 's hypothesis repeat loading dos clopidogrel ( 600 mg ) administration addition high dose clopidogrel continuous therapy ( 150 mg/day ) result high inhibition platelet ' aggregation patient myocardial infarction undergo interventional treatment compare standard therapy . Such treatment strategy cause increase risk bleeding complication . In many trial treatment repeat loading dos clopidogrel together high dose clopidogrel continuous therapy result : MACE reduction , improvement long term therapy result , low risk ischemic complication . Currently , data regard result treatment still limit .</brief_summary>
	<brief_title>Effect Repeated Loading Dose Clopidogrel High Dose Clopidogrel Continuous Therapy Platelet Aggregation Inhibition Patients With Myocardial Infarction Undergoing Interventional Treatment .</brief_title>
	<detailed_description>The objective study : - evaluate effect repeat load dose clopidogrel ( 600 mg ) addition high dose clopidogrel continuous therapy ( 150 mg/day ) platelet aggregation inhibition patient myocardial infarction undergo interventional treatment - evaluate safety repeat load dose clopidogrel ( 600 mg ) addition high dose clopidogrel continuous therapy ( 150 mg/day ) patient myocardial infarction undergo interventional treatment</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>•≥18 year age , Myocardial Infarction without ST segment elevation , clopidogrel treatment ( confirm administration load dose 600 mg chronic therapy 75 mg/day ) , sign write informed consent . prior administration fibrinolytic therapy and/or GP IIb/IIIa inhibitor within last 14 day , prior administration prasugrel within last 14 day , subject know hypersensitivity active ingredient component product increase risk bleed complication : bleeding diathesis , thrombocytopenia ( platelet count &lt; 100 000/mm3 ) , oral anticoagulant therapy ( INR &gt; 1.6 ) , uncontrolled hypertension ( systolic blood pressure &gt; 200 mmHg ) , major bleeding , trauma surgery within last 30 day , acute renal failure , acute liver failure , pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>STEMI</keyword>
	<keyword>NSTEMI</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>Areplex</keyword>
	<keyword>REL-0609</keyword>
</DOC>